Back to Search
Start Over
Additional file 7 of Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial
- Publication Year :
- 2022
- Publisher :
- figshare, 2022.
-
Abstract
- Additional file 7: Table S1. Primary and supportive endpoints in the full analysis data set. LSMean, least square mean; PaO2, arterial partial pressure of oxygen; FiO2, fraction of inspired oxygen; PaO2, partial pressure of arterial oxygen; ARDS, acute respiratory distress syndrome; CRP, C-reactive protein; CI, confidence interval; SD, standard deviation. *Based on the highest temperature in 24 h. Table S2. Follow-up endpoints. SD, standard deviation; DLCO, diffusing capacity of lung for carbon monoxide; HRCT, high-resolution computed tomography; WHO, world health organisation. 6-point ordinal scale: 2 on invasive mechanical ventilation; 3 on non-invasive ventilation or high flow oxygen devices; 4 hospitalized, requiring supplemental oxygen; 5 hospitalized, not requiring supplemental oxygen, 6 not hospitalized.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....8842fb2c25aa31faf98478fede16e49a
- Full Text :
- https://doi.org/10.6084/m9.figshare.20462401